Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes.
Journal: Clinical genitourinary cancer
Published: February 11, 2025
Clinical Outcomes With Immune Checkpoint Inhibitors in Patients With FGFR2/3, MTAP or ERBB2 Genomic Alterations in Advanced Urothelial Carcinoma.
Journal: Clinical genitourinary cancer
Published: September 12, 2024
Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor.
Journal: Clinical genitourinary cancer
Published: April 08, 2024
Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer.
Journal: Targeted oncology
Published: March 14, 2024
Showing 1-4 of 4
Last Updated: 09/26/2026